pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Ultragenyx Pharmaceutical Inc. ($RARE) · news · pharmadog
← back to Ultragenyx Pharmaceutical Inc.
News mentioning $RARE
837
stories
May 12, 26
STAT+: Hims’ sales miss as telehealth competition grows
stat
May 12, 26
Arvinas, Pfizer find new partner for ‘Protac’ breast cancer drug
biopharma dive
May 12, 26
Dr Parikh on the Feasibility and Importance of Immunotherapy Trials in Anal Cancer
onclive
May 12, 26
STAT+: Capsida says it still doesn’t know what caused gene therapy death
stat
May 12, 26
A year after Vertex’s big launch, pain drug research faces a pivotal moment
biopharma dive
May 11, 26
No FDA permission, no problem: New flavored vape policy worries experts
stat
May 11, 26
MimiVax and Roswell Park Open Phase 2 Trial of SurVaxM for Patients with Metastatic Neuroendocrine Tumors
onclive
May 11, 26
New home for Novo's Parkinson's cell therapy; GSK's deal to sell drug in China
endpoints
May 11, 26
STAT+: Astellas treatment offers new hope to a devastated rare disease community
stat
May 11, 26
Inhibrx delivers ‘differentiated’ cancer drug data; Fractyl starts diabetes gene therapy trial
biopharma dive
May 11, 26
The connection between periods and mental health
stat
May 11, 26
Precision in motion: Decoding the critical operations behind the logistics of next-generation cell and gene therapies
biopharma dive
May 11, 26
STAT+: Five years after disaster, a rare disease community gets new chance at treatment
stat
May 11, 26
STAT+: Medicare is spending far less than expected on new Alzheimer’s drugs
stat
May 11, 26
Animal skin disease confirmed in clusters of European men who have sex with men
stat
May 8, 26
Spain readies for evacuations as a hantavirus-hit cruise ship heads for the Canary Islands
stat
May 8, 26
Trump reportedly plans to fire FDA Commissioner Makary
stat
May 8, 26
FDA Approves Zenocutuzumab for NRG1 Fusion+ Cholangiocarcinoma
onclive
May 8, 26
Former FDA leaders, pharma speak out on mifepristone
stat
May 8, 26
The biotechs wear Prada
stat
May 8, 26
STAT+: The biotech news you need to read today
stat
May 8, 26
Lilly, Gilead lead pharma’s M&A boom
biopharma dive
May 8, 26
Why we left the FDA: Six former officials share their stories
stat
May 7, 26
Key takeaways from WHO briefing on hantavirus cruise ship outbreak
stat
May 7, 26
Science is becoming less disruptive. Is an aging workforce to blame?
stat
May 7, 26
Official leading CDC’s cruise ship program retires
stat
May 7, 26
Sylvester Comprehensive Cancer Center Identifies a Screening Gap to Prevent a Type of Leukemia in the U.S.
onclive
May 7, 26
Angelini to buy Catalyst in $4B play for rare neuro drugs
biopharma dive
May 7, 26
STAT+: Pharmalittle: We’re reading about Sanofi and an FDA voucher, FDA rethinking a rejection, and more
stat
May 7, 26
STAT+: FDA revisits a rare cancer treatment it rejected a few months ago
stat
← prev
page 26 of 28
next →
